Vaccination of special populations: Protecting the vulnerable (Q28066325)

Ruprecht Schmidt-Ott

2

1 reference

Jose Ignacio Santos

3

1 reference

Lawrence R. Stanberry

4

1 reference

Annika M. Hofstetter

5

1 reference

Susan L. Rosenthal

6

1 reference

Anthony L. Cunningham

7

1 reference

language of work or name

1 reference

20 December 2016

1 reference

1 reference

34

1 reference

issue

52

1 reference

page(s)

6681-6690

1 reference

Adaptive immune responses during pregnancy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Vaccinations for pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Maternal benefits of immunization during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Effectiveness of maternal influenza immunization in mothers and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

A review of fetal and infant protection associated with antenatal influenza immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Introducing new vaccines in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Maternal and neonatal tetanus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Epidemiological and clinical reasons for vaccination against pertussis and influenza in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Control of pertussis in infants: time has finally come?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Effectiveness of maternal pertussis vaccination in England: an observational study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Understanding factors influencing vaccination acceptance during pregnancy globally: A literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Enrolling pregnant women in research--lessons from the H1N1 influenza pandemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Safety of pertussis vaccination in pregnant women in UK: observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Knowledge and attitiudes of pregnant women and their providers towards recommendations for immunization during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunogenicity, safety and tolerability of vaccinations in premature infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Perinatal Risk Factors for Hospitalization for Pneumococcal Disease in Childhood: A Population-Based Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunisation practices in infants born prematurely: neonatologists' survey and clinical audit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Improving preterm infants' immunisation status: a follow-up audit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Safety of rotavirus vaccine in the NICU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Rotavirus vaccination of very low birth weight infants at discharge from the NICU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Underimmunization at discharge from the neonatal intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunization in special populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Vaccinations for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Updates in vaccination: recommendations for adult inflammatory bowel disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Diabetes and infection: assessing the association with glycaemic control in population-based studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunisation in the current management of cystic fibrosis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immune regulation of human herpesviruses and its implications for human transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

A review of guidance on immunization in persons with defective or deficient splenic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Prevention and management of infections in patients without a spleen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Use of influenza and pneumococcal vaccines in people with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

A population based study of the epidemiology of Herpes Zoster and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

A systematic review and meta-analysis of risk factors for postherpetic neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Rates of pneumococcal disease in adults with chronic medical conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Vaccine coverage in CF children: A French multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Adherence to Guidelines for Hepatitis B, Pneumococcal, and Influenza Vaccination in Patients With Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Interventions to Improve Adolescent Vaccination: What May Work and What Still Needs to Be Tested

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Adolescents with a chronic condition: challenges living, challenges treating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Human papillomavirus vaccination in female pediatric cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunization coverage and timeliness of vaccination in Italian children with chronic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Preventive services received by adolescents with cystic fibrosis and sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Factors impacting HPV vaccination: lessons for health care professionals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Immunosenescence: Implications for response to infection and vaccination in older people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Epidemiology of pneumococcal disease in a national cohort of older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Long-term persistence of zoster vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Factors affecting the uptake of vaccination by the elderly in Western society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Vaccine strategies to enhance immune responses in the aged

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Vaccines for the elderly need to be introduced into the immunization program in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

Effectiveness of short message services reminder on childhood immunization programme in Kadoma, Zimbabwe - a randomized controlled trial, 2013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

The Mobile Solutions for Immunization (M-SIMU) Trial: A Protocol for a Cluster Randomized Controlled Trial That Assesses the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.015

10.1016/J.VACCINE.2016.11.015

7 January 2021

Identifiers

DOI

0 references

Fatcat ID

release_7q35kvvamveifgeofgywsaolae

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7q35kvvamveifgeofgywsaolae

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed publication ID

27876197

1 reference